Diaceutics PLC (AIM:DXRX)

Market Cap	100.17M
Revenue (ttm)	32.16M
Net Income (ttm)	-1.70M
Shares Out	84.53M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	131.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	73,617
Average Volume	133,658
Open	119.50
Previous Close	118.50
Day's Range	117.36 - 120.00
52-Week Range	106.00 - 151.00
Beta	0.80
RSI	40.95
Earnings Date	Jun 17, 2025

About Diaceutics

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using p...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2005
• Employees: 199
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: DXRX

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.